Biotech and Pharma

[ad_1] BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for…

[ad_1] Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this…

[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients…

[ad_1] Multinational pharmaceutical company Pfizer is in discussions to acquire biotech firm Seagen in a deal that could be worth…

[ad_1] Moderna stock fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings…

[ad_1] An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said,…

[ad_1] Johnson & Johnson recently increased an investment in an embattled biotech stock, and slashed a position in a maker…

[ad_1] To the Editor: Pfizer has a lot of good and bad points, as mentioned in your cover story “Pfizer…

[ad_1] Catalent stock surged nearly 25% in premarket trading Monday following a report that life sciences company Danaher has expressed…

[ad_1] Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped…